Biallelic loss of function variants in

WBP4 pre-mRNA splicing spliceosome syndromic neurodevelopmental disorder

Journal

medRxiv : the preprint server for health sciences
Titre abrégé: medRxiv
Pays: United States
ID NLM: 101767986

Informations de publication

Date de publication:
27 Jun 2023
Historique:
pubmed: 10 7 2023
medline: 10 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

Over two dozen spliceosome proteins are involved in human diseases, also referred to as spliceosomopathies. WBP4 (WW Domain Binding Protein 4) is part of the early spliceosomal complex, and was not described before in the context of human pathologies. Ascertained through GeneMatcher we identified eleven patients from eight families, with a severe neurodevelopmental syndrome with variable manifestations. Clinical manifestations included hypotonia, global developmental delay, severe intellectual disability, brain abnormalities, musculoskeletal and gastrointestinal abnormalities. Genetic analysis revealed overall five different homozygous loss-of-function variants in

Identifiants

pubmed: 37425688
doi: 10.1101/2023.06.19.23291425
pmc: PMC10327195
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NICHD NIH HHS
ID : K23 HD102589
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States

Commentaires et corrections

Type : UpdateIn

Déclaration de conflit d'intérêts

DECLARATION OF INTERESTS HMS is an employee of Geneyx Genomics. Other authors declare no conflict of interest.

Auteurs

Eden Engal (E)

Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Department of Military Medicine and "Tzameret", Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Kaisa Teele Oja (KT)

Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Reza Maroofian (R)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK.

Ophir Geminder (O)

Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.
Department of Military Medicine and "Tzameret", Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Thuy-Linh Le (TL)

Institute Imagine, Paris, France.

Evyatar Mor (E)

Department of computer science, Ben-Gurion University of the Negev.

Naama Tzvi (N)

Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.

Naama Elefant (N)

Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.

Maha S Zaki (MS)

Department of Clinical Genetics, Human Genetics and Genome Research Institute, Cairo, Egypt.

Joseph G Gleeson (JG)

Department of Neurosciences, University of California, San Diego, La Jolla, USA.
Rady Children's Institute for Genomic Medicine, San Diego, La Jolla, USA.

Kai Muru (K)

Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Sander Pajusalu (S)

Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Monica H Wojcik (MH)

Broad Institute of MIT and Harvard, Cambridge, MA.

Divya Pachat (D)

Aster MIMS, Kozhikode, Kerala, India.

Marwa Abd Elmaksoud (MA)

Neurology Unit, Alexandria University Children's Hospital, Department of Pediatrics, Faculty of Medicine, Alexandria University, Alexandria, Egypt.

Won Chan Jeong (WC)

3billion, Seoul, Korea.

Hane Lee (H)

3billion, Seoul, Korea.

Peter Bauer (P)

CENTOGENE N.V., Am Strande 7, 18055 Rostock, Germany.

Giovanni Zifarelli (G)

CENTOGENE N.V., Am Strande 7, 18055 Rostock, Germany.

Henry Houlden (H)

Department of Neuromuscular Disease, UCL Queen Square Institute of Neurology, London, UK.

Orly Elpeleg (O)

Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Chris Gordon (C)

Institute Imagine, Paris, France.

Tamar Harel (T)

Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Katrin Õunap (K)

Genetics and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.

Maayan Salton (M)

Department of Biochemistry and Molecular Biology, The Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 9112102, Israel.

Hagar Mor-Shaked (H)

Department of Genetics, Hadassah Medical Organization, Jerusalem, Israel.
Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Classifications MeSH